Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... US$ 23.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1% during 2024-2034. The encephalitis market has been comprehensively analyzed in IMARC's new report titled "Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, ... Read More
-
Complicated Urinary Tract Infections (cUTIs) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... The complicated urinary tract infections (cUTIs) market has been comprehensively analyzed in IMARC's new report titled "Complicated Urinary Tract Infections (cUTIs) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Complicated urinary tract ... Read More
-
Sexually Transmitted Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... the 7MM to reach US$ 95.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.01% during 2024-2034. The sexually transmitted diseases market has been comprehensively analyzed in IMARC's new report titled "Sexually Transmitted Diseases ... Read More
-
Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... IMARC's new report titled "Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Myopia, also known as nearsightedness, refers to a refractive error of the eye that makes distant objects appear blurry ... Read More
-
Hereditary Angioedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034
... to reach US$ 3.5 Billion by 2034, exhibiting a growth rate (CAGR) of 6.1% during 2024-2034. Hereditary Angioedema Market is currently witnessing strong growth driven by advances in identifying mechanisms of angioedema and developing modern ... Read More
-
Hypophosphatasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... US$ 1,036.4 Million by 2034, exhibiting a growth rate (CAGR) of 3.3% during 2024-2034. The hypophosphatasia market has been comprehensively analyzed in IMARC's new report titled "Hypophosphatasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, ... Read More
-
Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type, By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user, By Region, And Segment Forecasts, 2024 - 2030
... Clinical Trials Management System Market Growth & Trends The global clinical trials management system market size is anticipated to reach USD 4.73 billion by 2030 and is projected to grow at a CAGR of 14.65% ... Read More
-
Clinical Trials Packaging Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... was valued at USD 3.80 billion in 2023 and is projected to grow from USD 4.13 billion in 2024 to USD 8.54 billion by 2032, exhibiting a CAGR of 9.51% during the forecast period of ... Read More
-
Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis By Type (Candidiasis, Aspergillosis), By Treatment Approach, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
... a research report titled “Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition)” which provides a complete analysis of the Global Systemic Aspergillosis and Systemic Candidiasis industry in terms of market segmentation By Type (Candidiasis, ... Read More
-
Multiple Sclerosis Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 21.33 billion in 2023, and the market is now projected to grow from USD 21.16 billion in 2024 to USD 38.94 billion by 2032, exhibiting a CAGR of 7.9% during the forecast ... Read More
-
Clinical Trials Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 57.76 billion in 2023, and the market is now projected to grow from USD 61.58 billion in 2024 to USD 106.78 billion by 2032, exhibiting a CAGR of 7.1% during the forecast period of 2024-2032. ... Read More
-
2024 Global Forecast for Eclinical Solutions Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Clinical Laboratory Service Market Size Study & Forecast, By Test Type (Genetic Testing, Clinical Chemistry, Medical Microbiology Testing, Hematology Testing, Immunology Testing, Cytology Testing, Drug of Abuse Testing. Other Esoteric Tests) By Service Provider (Hospital-based Laboratories, Stand-alone Laboratories, Clinic-based Laboratories), By Application (Bioanalytical & Lab Chemistry Services, Toxicology Testing Services, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services, Drug Discovery & Development Related Services, Other Clinical Laboratory Services) and Regional Analysis, 2023-2030
... (Hospital-based Laboratories, Stand-alone Laboratories, Clinic-based Laboratories), By Application (Bioanalytical & Lab Chemistry Services, Toxicology Testing Services, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services, Drug Discovery & Development Related Services, Other ... Read More
-
2024 Global Forecast for Electronic Clinical Outcome Assessment Solutions Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
Global Drug Screening Databank Market Report
... 2031. Drug Screening Service segment is expected to be the highest contributor to this market, with $2,091.3 Million in 2022, and is anticipated to reach $5,840.6 Million by 2031, registering a CAGR of 12.15%. Drug ... Read More
-
Global Investigational Drug CDMO Databank Market Report.pdf
... from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of 5.40%. ... Read More
-
Global Cell And Gene Therapy Clinical Trials Databank Market Report
... at a CAGR of 6.20% from 2021 to 2029. Cardiology segment is expected to be the highest contributor to this market, with $9,361.8 Million in 2020, and is anticipated to reach $16,753.6 Million by 2029, ... Read More
-
Global In Silico Clinical Trials Databank Market Report
... 5.99% from 2023 to 2031. Medical Devices segment is expected to be the highest contributor to this market, with $1,461.1 Million in 2022, and is anticipated to reach $2,538.7 Million by 2031, registering a CAGR ... Read More
-
Global Investigational Drug CDMO Databank Market Report
... 2023 to 2031. Small Molecule segment is expected to be the highest contributor to this market, with $3,991.1 Million in 2022, and is anticipated to reach $6,166.8 Million by 2031, registering a CAGR of 5.00%. ... Read More
-
Global Idiopathic Pulmonary Fibrosis Treatment Databank Market Report
... 10.94% from 2021 to 2029. MAPK Inhibitors segment is expected to be the highest contributor to this market, with $1,304.4 Million in 2020, and is anticipated to reach $3,116.3 Million by 2029, registering a CAGR ... Read More
-
Post-operative Pain (POP) - Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast for POP. Most marketed drugs for POP are enzyme inhibitors, followed by receptor agonists, by mechanism of action. Phase III pipeline for POP is robust and includes ... Read More
-
Friedreich Ataxia (FRDA) - Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast for FRDA. The marketed drugs space for FRDA is limited to just two approved drugs, Biogen's Skyclarys (omaveloxolone) is the leading drug in FRDA space. R&D ... Read More
-
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Mycosis Fungoides - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Epilepsy - Global Clinical Trials Review, 2024
... the clinical trials on Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
Research Assistance
